Akèy › Adenokasinom Ezofajyen › Pennsylvania › Philadelphia
Etid klinik pou Adenokasinom Ezofajyen nan Philadelphia, PA
8 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Ap rekriteFaz 2/3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi lwen
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Ap rekriteFaz 3
- Thomas Jefferson University Hospital, Philadelphia
- Einstein Medical Center Philadelphia, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi lwen
- ak 2 plis
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Ap rekriteFaz 2/3
- Alliance Cancer Specialists, PC, Wynnewood · 7 mi lwen
- Alliance Cancer Specialists, PC, Media · 12 mi lwen
- Alliance Cancer Specialists, PC, Horsham · 16 mi lwen
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Ap rekriteFaz 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Ap rekrite
- University of Pennsylania, Perelman School of Medicine, Philadelphia
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Ap rekriteFaz 3
- Research Site, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Ap rekriteFaz 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Ap rekriteFaz 2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Etid Adenokasinom Ezofajyen nan lòt vil
- New York City, NY18 etid
- Boston, MA13 etid
- Houston, TX12 etid
- Nashville, TN11 etid
- Arlington, VA11 etid
- Durham, NC10 etid
- Jacksonville, FL9 etid
- Baldwin Park, CA9 etid
- Rochester, MN9 etid
- St. Louis, MO9 etid
- Queens, NY9 etid
- Los Angeles, CA9 etid
Lòt etid nan Philadelphia
- Kansè (tout kalite)59 etid
- Kansè nan tete56 etid
- Kansè Poumon ki pa ti selil51 etid
- Kansè Metastatik46 etid
- Kansè pwostat44 etid
- Kansè kolorektal44 etid
- Kansè ovè44 etid
- Kansè poumon36 etid
- Leksemi mieloïd egi34 etid
- Ensifizyans kadyak31 etid
- Kansè Endomèt28 etid
- Depresyon26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.